Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- S.934
S.934: FDA Reauthorization Act of 2017
About This Bill
- This bill was introduced in the 115th Congress
- This bill is primarily about health
- Introduced April 25, 2017
- Latest Major Action May 11, 2017
- See the two similar bills introduced in other congresses.
Bill Sponsor
Bill Cosponsor
Bill Versions
- Reported to Senate - May 11, 2017
- Introduced in Senate - April 25, 2017
Bill Summary
FDA Reauthorization Act of 2017 TITLE I--FEES RELATING TO DRUGS Prescription Drug User Fee Amendments of 2017 (Sec. 102) This bill amends the Federal Food, Drug, and Cosmetic Act to extend through FY2022 and revise Food and Drug Administration (FDA) user fees for new drug applications. User fees are eliminated for supplements to new drug applications and drug manufacturing facilities. TITLE II--FEES RELATING TO DEVICES Medical Device User Fee...
(Source: Library of Congress)
What Lawmakers Are Saying About This Bill
Congressional Budget Office Estimate
Bill Actions
| Date | Description |
|---|---|
| May 11, 2017 |
Placed on Senate Legislative Calendar under General Orders. Calendar No. 76.
|
| May 11, 2017 |
Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.
|
| May 11, 2017 |
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
|
| April 25, 2017 |
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
|
| April 25, 2017 |
Introduced in the Senate by Lamar Alexander (R-Tenn.) |